Nantahala Capital Management »

Milestone Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 1.8M 1.79

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Ser Tr S&p Biotech (XBI)
Establishment Labs Holdings Ord (ESTA)
Soleno Therapeutics (SLNO)
Eli Lilly & Co. Put Option (LLY)
Grand Canyon Education Put Option (LOPE)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Evolus (EOLS)
Peloton Interactive Cl A Com (PTON)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)
Bioventus Com Cl A (BVS)
Rumbleon Com Cl B (RMBL)
Ishares Tr U.s. Real Es Etf Put Option (IYR)

View all positions for Nantahala Capital Management

Top funds holding Milestone Pharmaceuticals

BlackRock
Millennium Management
Alta Fundamental Advisers
Lion Point Capital
Citadel Advisors
OrbiMed Advisors
Nantahala Capital Management
Goldman Sachs Group
Bleichroeder
Altium Capital Management
Morgan Stanley
Velan Capital Investment Management
BML Capital Management
Monashee Investment Management
Ikarian Capital

View all funds holding Milestone Pharmaceuticals